SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-010769
Filing Date
2023-08-14
Accepted
2023-08-14 16:17:45
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zivo_10q.htm   iXBRL 10-Q 775345
2 CERTIFICATION zivo_ex311.htm EX-31.1 8071
3 CERTIFICATION zivo_ex312.htm EX-31.2 7835
4 CERTIFICATION zivo_ex321.htm EX-32.1 3150
5 CERTIFICATION zivo_ex322.htm EX-32.2 3165
  Complete submission text file 0001654954-23-010769.txt   3653018

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA zivo-20230630.xsd EX-101.SCH 37973
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20230630_lab.xml EX-101.LAB 196923
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20230630_cal.xml EX-101.CAL 37058
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20230630_pre.xml EX-101.PRE 164985
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20230630_def.xml EX-101.DEF 76610
50 EXTRACTED XBRL INSTANCE DOCUMENT zivo_10q_htm.xml XML 625801
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40449 | Film No.: 231170502
SIC: 2836 Biological Products, (No Diagnostic Substances)